Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates

Overview

Journal Curr Top Behav Neurosci

Publisher Springer

Specialty Psychology

Date 2017 Apr 13

PMID 28401522

Citations 66

Authors

Frederick S Barrett

Roland R Griffiths

Affiliations

Soon will be listed here.

Abstract

This chapter begins with a brief review of descriptions and definitions of mystical-type experiences and the historical connection between classic hallucinogens and mystical experiences. The chapter then explores the empirical literature on experiences with classic hallucinogens in which claims about mystical or religious experiences have been made. A psychometrically validated questionnaire is described for the reliable measurement of mystical-type experiences occasioned by classic hallucinogens. Controlled laboratory studies show that under double-blind conditions that provide significant controls for expectancy bias, psilocybin can occasion complete mystical experiences in the majority of people studied. These effects are dose-dependent, specific to psilocybin compared to placebo or a psychoactive control substance, and have enduring impact on the moods, attitudes, and behaviors of participants as assessed by self-report of participants and ratings by community observers. Other studies suggest that enduring personal meaning in healthy volunteers and therapeutic outcomes in patients, including reduction and cessation of substance abuse behaviors and reduction of anxiety and depression in patients with a life-threatening cancer diagnosis, are related to the occurrence of mystical experiences during drug sessions. The final sections of the chapter draw parallels in human neuroscience research between the neural bases of experiences with classic hallucinogens and the neural bases of meditative practices for which claims of mystical-type experience are sometimes made. From these parallels, a functional neural model of mystical experience is proposed, based on changes in the default mode network of the brain that have been observed after the administration of classic hallucinogens and during meditation practices for which mystical-type claims have been made.

Citing Articles

The Therapeutic Potential of Psychedelics on Reducing Rumination: A Mini-Review.

Ramarushton B, Blumenthal H, Ryals A, Boals A, Thompson L Psychedelic Med (New Rochelle). 2025; 2(3):146-152.

PMID: 40051683 PMC: 11658672. DOI: 10.1089/psymed.2024.0009.

Further education in psychedelic-assisted therapy - experiences from Switzerland.

Aicher H, Muller F, Gasser P BMC Med Educ. 2025; 25(1):341.

PMID: 40045361 PMC: 11881254. DOI: 10.1186/s12909-025-06871-y.

Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being.

Bonnelle V, Feilding A, Rosas F, Nutt D, Carhart-Harris R, Timmermann C J Psychopharmacol. 2024; 38(10):887-896.

PMID: 39301949 PMC: 11512487. DOI: 10.1177/02698811241276788.

Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine.

Avram M, Fortea L, Wollner L, Coenen R, Korda A, Rogg H Mol Psychiatry. 2024; .

PMID: 39261671 DOI: 10.1038/s41380-024-02734-y.

LSD-assisted therapy in patients with anxiety: open-label prospective 12-month follow-up.

Holze F, Gasser P, Muller F, Strebel M, Liechti M Br J Psychiatry. 2024; 225(3):362-370.

PMID: 39078038 PMC: 11536188. DOI: 10.1192/bjp.2024.99.

References

Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M . Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG. Neuropsychopharmacology. 1999; 20(6):565-81. DOI: 10.1016/S0893-133X(98)00089-X. View

von Stein A, Sarnthein J . Different frequencies for different scales of cortical integration: from local gamma to long range alpha/theta synchronization. Int J Psychophysiol. 2000; 38(3):301-13. DOI: 10.1016/s0167-8760(00)00172-0. View

Raichle M, MacLeod A, Snyder A, Powers W, Gusnard D, Shulman G . A default mode of brain function. Proc Natl Acad Sci U S A. 2001; 98(2):676-82. PMC: 14647. DOI: 10.1073/pnas.98.2.676. View

Newberg A, Alavi A, Baime M, Pourdehnad M, SANTANNA J, DAquili E . The measurement of regional cerebral blood flow during the complex cognitive task of meditation: a preliminary SPECT study. Psychiatry Res. 2001; 106(2):113-22. DOI: 10.1016/s0925-4927(01)00074-9. View

Riba J, Anderer P, Morte A, Urbano G, Jane F, Saletu B . Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers. Br J Clin Pharmacol. 2002; 53(6):613-28. PMC: 1874340. DOI: 10.1046/j.1365-2125.2002.01609.x. View

Kelley W, Macrae C, Wyland C, Caglar S, Inati S, Heatherton T . Finding the self? An event-related fMRI study. J Cogn Neurosci. 2002; 14(5):785-94. DOI: 10.1162/08989290260138672. View

Newberg A, Iversen J . The neural basis of the complex mental task of meditation: neurotransmitter and neurochemical considerations. Med Hypotheses. 2003; 61(2):282-91. DOI: 10.1016/s0306-9877(03)00175-0. View

Hermle L, Funfgeld M, Oepen G, Botsch H, Borchardt D, Gouzoulis E . Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research. Biol Psychiatry. 1992; 32(11):976-91. DOI: 10.1016/0006-3223(92)90059-9. View

Nichols D . Hallucinogens. Pharmacol Ther. 2004; 101(2):131-81. DOI: 10.1016/j.pharmthera.2003.11.002. View

10.

Riba J, Anderer P, Jane F, Saletu B, Barbanoj M . Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography. Neuropsychobiology. 2004; 50(1):89-101. DOI: 10.1159/000077946. View

11.

Fox M, Snyder A, Vincent J, Corbetta M, Van Essen D, Raichle M . The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A. 2005; 102(27):9673-8. PMC: 1157105. DOI: 10.1073/pnas.0504136102. View

12.

El-Seedi H, De Smet P, Beck O, Possnert G, Bruhn J . Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas. J Ethnopharmacol. 2005; 101(1-3):238-42. DOI: 10.1016/j.jep.2005.04.022. View

13.

Halpern J, Sherwood A, Hudson J, Yurgelun-Todd D, Pope Jr H . Psychological and cognitive effects of long-term peyote use among Native Americans. Biol Psychiatry. 2005; 58(8):624-31. DOI: 10.1016/j.biopsych.2005.06.038. View

14.

Northoff G, Heinzel A, de Greck M, Bermpohl F, Dobrowolny H, Panksepp J . Self-referential processing in our brain--a meta-analysis of imaging studies on the self. Neuroimage. 2006; 31(1):440-57. DOI: 10.1016/j.neuroimage.2005.12.002. View

15.

Riba J, Romero S, Grasa E, Mena E, Carrio I, Barbanoj M . Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant. Psychopharmacology (Berl). 2006; 186(1):93-8. DOI: 10.1007/s00213-006-0358-7. View

16.

Svoboda E, McKinnon M, Levine B . The functional neuroanatomy of autobiographical memory: a meta-analysis. Neuropsychologia. 2006; 44(12):2189-208. PMC: 1995661. DOI: 10.1016/j.neuropsychologia.2006.05.023. View

17.

Griffiths R, Richards W, McCann U, Jesse R . Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl). 2006; 187(3):268-83. DOI: 10.1007/s00213-006-0457-5. View

18.

Gilbert S, Spengler S, Simons J, Douglas Steele J, Lawrie S, Frith C . Functional specialization within rostral prefrontal cortex (area 10): a meta-analysis. J Cogn Neurosci. 2006; 18(6):932-48. DOI: 10.1162/jocn.2006.18.6.932. View

19.

Newberg A, Wintering N, Morgan D, Waldman M . The measurement of regional cerebral blood flow during glossolalia: a preliminary SPECT study. Psychiatry Res. 2006; 148(1):67-71. DOI: 10.1016/j.pscychresns.2006.07.001. View

20.

Mason M, Norton M, Van Horn J, Wegner D, Grafton S, Neil Macrae C . Wandering minds: the default network and stimulus-independent thought. Science. 2007; 315(5810):393-5. PMC: 1821121. DOI: 10.1126/science.1131295. View